Publications by authors named "Martin J Cannon"

53Publications

Gastrointestinal Tract Dysbiosis Enhances Distal Tumor Progression through Suppression of Leukocyte Trafficking.

Cancer Res 2019 12 7;79(23):5999-6009. Epub 2019 Oct 7.

Department of Radiation Oncology, University of Arkansas for Medical Sciences, Little Rock, Arkansas.

View Article and Find Full Text PDF
December 2019

The evolving clinical landscape for dendritic cell vaccines and cancer immunotherapy.

Immunotherapy 2019 02;11(2):75-79

Department of Immunology, Mayo Clinic Florida, 4500 San Pablo Road S, Jacksonville, FL 32224, USA.

View Article and Find Full Text PDF
February 2019

Regulatory T Cells in Gynecologic Cancer.

MOJ Immunol 2018 16;6(2):34-42. Epub 2018 Mar 16.

Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR USA.

View Article and Find Full Text PDF
March 2018

Further clinical advancement of dendritic cell vaccination against ovarian cancer.

Ann Res Hosp 2018 Aug 23;2. Epub 2018 Aug 23.

Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

View Article and Find Full Text PDF
August 2018

Signaling Circuits and Regulation of Immune Suppression by Ovarian Tumor-Associated Macrophages.

Vaccines (Basel) 2015 May 29;3(2):448-66. Epub 2015 May 29.

Department of Internal Medicine, University of Arkansas for Medical Sciences, 4301 West Markham, Little Rock, AR 72205, USA.

View Article and Find Full Text PDF
May 2015

Galectin-3 inhibition suppresses drug resistance, motility, invasion and angiogenic potential in ovarian cancer.

Gynecol Oncol 2014 Dec 6;135(3):573-9. Epub 2014 Oct 6.

Department of Internal Medicine at the Division of Hematology & Oncology & Oncology, The Southwest Cancer Treatment and Research Center, Texas Tech University Health Sciences Center, Lubbock, TX, USA; Laura W Bush Institute for Women's Health and Center for Women's Health and Gender-Based Medicine, Amarillo, TX, USA; Kiromic, Inc., Lubbock, TX, USA.

View Article and Find Full Text PDF
December 2014

Ovarian tumor ascites CD14+ cells suppress dendritic cell-activated CD4+ T-cell responses through IL-10 secretion and indoleamine 2,3-dioxygenase.

J Immunother 2014 Apr;37(3):163-9

Departments of *Microbiology and Immunology †Obstetrics and Gynecology, University of Arkansas for Medical Sciences, Little Rock, AR.

View Article and Find Full Text PDF
April 2014

Dendritic cell vaccination, immune regulation, and clinical outcomes in ovarian cancer.

Front Immunol 2013 Nov 18;4:382. Epub 2013 Nov 18.

Department of Pathology, University of Arkansas for Medical Sciences , Little Rock, AR , USA.

View Article and Find Full Text PDF
November 2013

Modulation of p38 MAPK signaling enhances dendritic cell activation of human CD4+ Th17 responses to ovarian tumor antigen.

Cancer Immunol Immunother 2013 May 25;62(5):839-49. Epub 2013 Jan 25.

Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.

View Article and Find Full Text PDF
May 2013

The case for HER2/neu as a therapeutic target for gynecologic malignancies.

Immunotherapy 2012 Aug;4(8):781-4

Department of Microbiology & Immunology, Department of Obstetrics & Gynecology, Division of Gynecologic Oncology, University of Arkansas for Medical Sciences, 4301 West Markham, Little Rock, AR 72205, USA.

View Article and Find Full Text PDF
August 2012

CD4+ T-cell response against human papillomavirus type 16 E6 protein is associated with a favorable clinical trend.

Cancer Immunol Immunother 2012 Jan 13;61(1):63-70. Epub 2011 Aug 13.

Department of Pathology, College of Medicine, University of Arkansas for Medical Sciences, 4301 West Markham Street, Slot 502, Little Rock, AR 72205, USA.

View Article and Find Full Text PDF
January 2012

Cancer testis antigen, ropporin, is a potential target for multiple myeloma immunotherapy.

J Immunother 2011 Jul-Aug;34(6):490-9

Division of Hematology and Oncology, Texas Tech University Health Sciences Center and the Southwest Cancer Treatment and Research Center, Lubbock, TX 79430, USA.

View Article and Find Full Text PDF
October 2011

Cancer testis antigens: novel biomarkers and targetable proteins for ovarian cancer.

Int Rev Immunol 2011 Apr-Jun;30(2-3):127-37

Division of Hematology & Oncology and Texas Tech University Health Sciences Center, Lubbock, Texas 79430, USA.

View Article and Find Full Text PDF
September 2011

Understanding the cross-talk between ovarian tumors and immune cells: mechanisms for effective immunotherapies.

Int Rev Immunol 2011 Apr-Jun;30(2-3):71-86

Department of Internal Medicine at Division of Hematology/Oncology, Texas Tech University Health Sciences Center and Southwest Cancer Treatment and Research Center, Lubbock, Texas 79430, USA.

View Article and Find Full Text PDF
September 2011

Identification of AKAP-4 as a new cancer/testis antigen for detection and immunotherapy of prostate cancer.

Prostate 2012 Jan 25;72(1):12-23. Epub 2011 Apr 25.

Division of Hematology & Oncology, Texas Tech University Health Sciences Center and The Southwest Cancer Treatment and Research Center, Lubbock, Texas 79430, USA.

View Article and Find Full Text PDF
January 2012

Cellular immunotherapy for ovarian cancer.

Expert Opin Biol Ther 2009 Jun;9(6):677-88

University of Arkansas for Medical Sciences, Department of Microbiology and Immunology, 4301 West Markham, Little Rock, AR 72205, USA.

View Article and Find Full Text PDF
June 2009

Advances in dendritic-cell-based therapeutic vaccines for cervical cancer.

Expert Rev Anticancer Ther 2007 Oct;7(10):1473-86

University of Arkansas for Medical Sciences, Department of Obstetrics & Gynecology, 4301 West Markham, Little Rock, AR 72205, USA.

View Article and Find Full Text PDF
October 2007

Recognition of a cervical cancer derived tumor cell line by a human papillomavirus type 16 E6 52-61-specific CD8 T cell clone.

Cancer Immun 2006 Jun 30;6. Epub 2006 Jun 30.

Department of Dermatology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.

View Article and Find Full Text PDF
June 2006

HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities.

Gynecol Oncol 2006 Mar 24;100(3):469-78. Epub 2005 Oct 24.

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Arkansas for Medical Sciences, 4301 W. Markham, Little Rock, AR 72205-7199, USA.

View Article and Find Full Text PDF
March 2006

Therapeutic vaccines for cervical cancer: dendritic cell-based immunotherapy.

Curr Pharm Des 2005 ;11(27):3485-500

Department of Obstetrics and Gynecology, University of Arkansas for Medical Sciences, 4301 West Markham, Little Rock, AR 72205, USA.

View Article and Find Full Text PDF
January 2006

Definition of an immunogenic region within the ovarian tumor antigen stratum corneum chymotryptic enzyme.

Clin Cancer Res 2005 May;11(9):3446-54

Department of Microbiology, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.

View Article and Find Full Text PDF
May 2005

Virus-specific CD4+ and CD8+ cytotoxic T-cell responses and long-term T-cell memory in individuals vaccinated against polio.

J Virol 2005 May;79(10):5988-95

Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, 4301 W. Markham St., Slot 511, Little Rock, AR 72205, USA.

View Article and Find Full Text PDF
May 2005

An HLA-E single chain trimer inhibits human NK cell reactivity towards porcine cells.

Mol Immunol 2005 Jun 8;42(10):1205-14. Epub 2005 Jan 8.

Central Arkansas Veterans Healthcare System, University of Arkansas for Medical Sciences 151 Research, 4300 West 7th Street, Little Rock, AR 72205, USA.

View Article and Find Full Text PDF
June 2005

Endemic Burkitt's lymphoma: a polymicrobial disease?

Nat Rev Microbiol 2005 02;3(2):182-7

Department of Microbiology and Immunology, SUNY Upstate Medical University, Syracuse, New York, USA.

View Article and Find Full Text PDF
February 2005

Dendritic cells and macrophages are productively infected by poliovirus.

J Virol 2005 Jan;79(1):401-9

Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.

View Article and Find Full Text PDF
January 2005

Current treatment options for endometrial cancer.

Expert Rev Anticancer Ther 2004 Aug;4(4):679-89

University of Arkansas for Medical Sciences, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, 4301 West Markham Street, Slot 518, Little Rock, AR 72205, USA.

View Article and Find Full Text PDF
August 2004

Increased levels of gangliosides in the plasma and ascitic fluid of patients with advanced ovarian cancer.

BJOG 2004 Jun;111(6):613-8

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.

View Article and Find Full Text PDF
June 2004

Immunological treatment of ovarian cancer.

Curr Opin Obstet Gynecol 2004 Feb;16(1):87-92

Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.

View Article and Find Full Text PDF
February 2004

Selection of HER-2/neu-positive tumor cells in early stage cervical cancer: implications for Herceptin-mediated therapy.

Gynecol Oncol 2003 Oct;91(1):231-40

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Arkansas for Medical Sciences, Little Rock, AR 72205-7199, USA.

View Article and Find Full Text PDF
October 2003

Novel target antigens for dendritic cell-based immunotherapy against ovarian cancer.

Expert Rev Anticancer Ther 2002 Feb;2(1):97-105

Department of Obstetrics and Gynecology, University of Arkansas for Medical Sciences, 4301 West Markham, Little Rock, AR 72205, USA.

View Article and Find Full Text PDF
February 2002

Overexpression of HER-2/neu in uterine serous papillary cancer.

Clin Cancer Res 2002 May;8(5):1271-9

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Arkansas, Little Rock 72205-7199, USA.

View Article and Find Full Text PDF
May 2002